Extracorporeal Shockwave Therapy (ESWT), otherwise referred to as shockwave therapy, was first introduced into clinical practice in 1982 for the management of urologic conditions. ESWT is an advanced treatment that uses acoustic shockwaves to break up soft tissue calcifications, enhance collagen synthesis, release growth factors, and stimulate your body’s healing process to improve pain and help you stay active. This therapy enhances blood circulation and accelerates the healing of stubborn musculoskeletal conditions in bones, tendons, ligaments, and muscle.
Shockwaves are transient pressure disturbances that propagate rapidly in three-dimensional space. They are associated with a sudden rise from ambient pressure to their maximum pressure. Significant tissue effects include cavitation, which are consequent to the negative phase of the wave propagation.
Physiological Effects
Shockwave therapy may be used to:
There are two types of shockwave i.e., high energy and low energy.
High energy SWT
High energy SWT or “true” shockwaves are classified as short duration (approx. 10msec) high energy pulses (5-100MPa) that break the sound barrier, resulting in a shockwave. Our high energy shockwave technology allows the shockwave to be focused directly through the affected tissue, resulting in several effects:
Low energy SWT
This type of shockwave is more accurately described as a pressure wave and differs from “True” shock wave technology in the following ways: it is longer, slower, and less intense than true shockwaves.
Extracorporeal Shockwave Therapy (SWT) is a modality used for the treatment of a variety of musculoskeletal conditions, primarily applied to chronic conditions, particularly those affecting medium to large sized tendons and their insertions on bone such as: